659 related articles for article (PubMed ID: 25333812)
21. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
22. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
23. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
[TBL] [Abstract][Full Text] [Related]
24. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
25. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.
Liu W; Zhu F; Jiang Y; Sun D; Yang B; Yan H
Oncol Rep; 2013 Mar; 29(3):1183-8. PubMed ID: 23254641
[TBL] [Abstract][Full Text] [Related]
26. Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF.
Yang Y; Bai Y; Xie G; Zhang N; Ma YP; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2010 Feb; 25(1):65-73. PubMed ID: 20187798
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
28. Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA.
Wang X; Fu Z; Zhao Y; Wu X; Shen W
Eur J Cancer Prev; 2011 May; 20(3):190-8. PubMed ID: 21200325
[TBL] [Abstract][Full Text] [Related]
29. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
[TBL] [Abstract][Full Text] [Related]
30. Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors.
Chen ZY; Liang K; Xie MX; Wang XF; Lü Q; Zhang J
Adv Ther; 2009 Jan; 26(1):99-106. PubMed ID: 19083158
[TBL] [Abstract][Full Text] [Related]
31. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
Mattheolabakis G; Ling D; Ahmad G; Amiji M
Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
[TBL] [Abstract][Full Text] [Related]
33. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
[TBL] [Abstract][Full Text] [Related]
36. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
Song J; Cao L; Li Y
Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
[TBL] [Abstract][Full Text] [Related]
39. RNA interference targeting enhancer of polycomb1 exerts anti-tumor effects in lung cancer.
Che C; Zhang L; Huo J; Zhang Y
Int J Clin Exp Pathol; 2015; 8(1):361-7. PubMed ID: 25755723
[TBL] [Abstract][Full Text] [Related]
40. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]